These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1654375)

  • 21. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.
    Rosen E; Stapleton JT; McLinden J
    Vaccine; 1993; 11(7):706-12. PubMed ID: 8393604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells.
    Borovec SV; Anderson DA
    J Virol; 1993 Jun; 67(6):3095-102. PubMed ID: 8388489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus.
    Bishop NE; Anderson DA
    Virology; 1993 Dec; 197(2):616-23. PubMed ID: 8249284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foot-and-mouth disease virus capsid proteins VP0, VP1 and VP3 synthesized by "in vitro" translation are the major components of 14S particles.
    Grigera P; Vasquez C; Palmenberg A
    Acta Virol; 1985 Dec; 29(6):449-54. PubMed ID: 2869654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dense particles and slow sedimenting particles produced by ultraviolet irradiation of poliovirus.
    Wetz K; Zeichhardt H; Willingmann P; Habermehl KO
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1263-75. PubMed ID: 6304233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus.
    Nasser AM; Metcalf TG
    Appl Environ Microbiol; 1987 Dec; 53(12):2967-71. PubMed ID: 2829721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The reproduction of the hepatitis A virus in cell cultures].
    Farashian VR; Bychenko AB; Artemov EK; Kuzaeva IA
    Vopr Virusol; 1991; 36(3):209-12. PubMed ID: 1654008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hepatitis A virus RNA and capsid antigen in individual cells.
    Harmon SA; Summers DF; Ehrenfeld E
    Virus Res; 1989 Apr; 12(4):361-9. PubMed ID: 2543159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poliovirus subviral particles associated with progeny RNA in the replication complex.
    Pfister T; Egger D; Bienz K
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():63-71. PubMed ID: 7844543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatitis A virus proteins in infected BS-C-1 cells.
    Updike WS; Tesar M; Ehrenfeld E
    Virology; 1991 Nov; 185(1):411-8. PubMed ID: 1656592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and classification of virus particles associated with hepatitis A. I. Size, density, and sedimentation.
    Siegl G; Frösner GG
    J Virol; 1978 Apr; 26(1):40-7. PubMed ID: 206730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary characterization of a fast-growing strain of human hepatitis A virus.
    Divizia M; Ruggeri F; Hentschel J; Flehmig B; Panà A; Perez-Bercoff R
    Microbiologica; 1986 Jul; 9(3):269-78. PubMed ID: 3018450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition.
    Cho MW; Ehrenfeld E
    Virology; 1991 Feb; 180(2):770-80. PubMed ID: 1846497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and assembly of poliovirus-related 45 S particles.
    Rombaut B; Vrijsen R; Delgadillo R; Vanden Berghe D; Boeyé A
    Virology; 1985 Oct; 146(1):111-9. PubMed ID: 2412342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of a hepatitis A virus candidate vaccine strain.
    Heinricy U; Stierhof YD; Pfisterer M; Flehmig B
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2487-93. PubMed ID: 2821186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of 'dense particles' from poliovirus-infected HeLa cells.
    Yamaguchi-Koll U; Wiegers KJ; Drzeniek R
    J Gen Virol; 1975 Mar; 26(3):307-19. PubMed ID: 164520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-scale purification of inactivated hepatitis A virus by centrifugation in non-ionic gradients.
    Dubois DR; Eckels KH; Ticehurst J; Binn LN; Timchak RL; Barvir DA; Rankin CT; O'Neill SP
    J Virol Methods; 1991 May; 32(2-3):327-34. PubMed ID: 1651954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restricted replication of hepatitis A virus in cell culture: encapsidation of viral RNA depletes the pool of RNA available for replication.
    Anderson DA; Ross BC; Locarnini SA
    J Virol; 1988 Nov; 62(11):4201-6. PubMed ID: 2845131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.